1877.HK - Shanghai Junshi Biosciences Co., Ltd.

HKSE - HKSE Delayed price. Currency in HKD
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-1,640,420
-2,386,067
-718,557
-1,665,639
-743,922
Depreciation & amortisation
59,591
293,654
262,559
151,362
59,591
Stock-based compensation
11,797
91,911
192,754
30,728
11,797
Change in working capital
-464,067
687,188
-318,773
-13,068
-464,067
Inventory
-132,198
-136,394
-154,823
-166,986
-132,198
Other working capital
-1,684,343
-2,169,277
-1,528,129
-2,091,488
-2,050,183
Other non-cash items
-39,947
-57,315
-11,976
7,315
-39,947
Net cash provided by operating activities
-1,147,714
-1,775,325
-641,901
-1,498,806
-1,187,034
Cash flows from investing activities
Investments in property, plant and equipment
-536,629
-393,952
-886,228
-592,682
-863,149
Acquisitions, net
-381,000
-96,000
-440,084
0
-73,746
Purchases of investments
-431,514
-8,484
-1,169,620
-245,166
-117,346
Sales/maturities of investments
351,753
0
565,284
70,135
72,200
Other investing activities
24,420
-29,071
22,506
41,636
-150
Net cash used for investing activities
-936,621
-467,619
-1,880,952
-697,976
-952,030
Net change in cash
-911,995
2,400,065
142,833
2,216,740
-1,545,482
Cash at beginning of period
4,268,654
3,504,605
3,384,998
1,214,026
2,763,570
Cash at end of period
3,356,659
5,996,936
3,504,605
3,384,998
1,214,026
Free cash flow
Operating cash flow
-1,147,714
-1,775,325
-641,901
-1,498,806
-1,187,034
Capital expenditure
-536,629
-393,952
-886,228
-592,682
-863,149
Free cash flow
-1,684,343
-2,169,277
-1,528,129
-2,091,488
-2,050,183